+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Maternal Serum Eye Drops in the Management of Pediatric Persistent Corneal Epithelial Defects: A Case Series



Maternal Serum Eye Drops in the Management of Pediatric Persistent Corneal Epithelial Defects: A Case Series



Cornea 37(7): 912-915



We report our experience with the use of maternally derived serum eye drops as adjunctive treatment in the management of pediatric persistent corneal epithelial defects. Five eyes of 4 patients were identified in a retrospective review of pediatric patients with persistent corneal epithelial defects who received maternal serum drops. Diagnoses associated with the defects comprised pontine tegmental cap dysplasia with bilateral cranial nerve V1, V2, V3, and VII palsies; pontine tegmental cap dysplasia with left cranial nerve V1, VII, and VIII palsies; traumatic left cranial nerve II, V1, V2, and VI palsies due to a basilar skull fracture; and Stevens-Johnson syndrome with ocular involvement. We evaluated the feasibility of using maternally derived serum drops; thus, we looked at the ability to prepare and tolerate the drops as well as any complications that could have been associated with treatment. Other data collected included visual acuity, corneal examination, and current and previous treatments. Both the duration of therapy and time of follow-up ranged from 5 to 28 months. All patients experienced improvement or resolution of their corneal epithelial defects within 3 weeks of initiating serum eye drops. Furthermore, there were no adverse effects from the use of allogeneic serum drops. Maternal serum eye drops are a well-tolerated and potentially beneficial addition to the management of pediatric persistent corneal epithelial defects.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 065301853

Download citation: RISBibTeXText

PMID: 29324584

DOI: 10.1097/ico.0000000000001512


Related references

Autologous serum eye drops for the treatment of persistent corneal epithelial defects. Journal of the College of Physicians and Surgeons--Pakistan 23(10): 737-739, 2013

Sterility of non-preserved autologous serum drops for treatment of persistent corneal epithelial defects. Der Ophthalmologe 101(7): 705-709, 2004

Treatment of Persistent Corneal Epithelial Defects After Vitreoretinal Surgery: Autologous Serum Eye Drops or a Bandage Contact Lens?. Cornea 27(9): 1097-1098, 2008

Autologous Serum Eye Drops Combined With Silicone Hydrogen Lenses for the Treatment of Postinfectious Corneal Persistent Epithelial Defects. Eye and Contact Lens 43(4): 225-229, 2017

Therapeutic outcomes of combined topical autologous serum eye drops with silicone-hydrogel soft contact lenses in the treatment of corneal persistent epithelial defects: A preliminary study. Contact Lens and Anterior Eye 39(6): 425-430, 2016

Umbilical cord blood serum therapy for the management of persistent corneal epithelial defects. International Journal of Ophthalmology 7(5): 807-810, 2014

Open clinical study of eye drops containing the fibronectin-derived peptide PHSRN for treatment of persistent corneal epithelial defects. Cornea 31(12): 1408-1413, 2012

Autologous Platelet-rich Plasma Eye Drops Accelerate Re-epithelialization of Post-keratoplasty Persistent Corneal Epithelial Defects. Journal of Ophthalmic and Vision Research 14(2): 131-135, 2019

A study of refractory cases of persistent epithelial defects associated with dry eye syndrome and recurrent corneal erosions successfully treated with cyclosporine A 0.05% eye drops. Drug Design, Development and Therapy Volume 13: 2001-2008, 2019

Autologous serum eye drops for treating persistent corneal epithelial defect after vitreoretinal surgery. Cornea 27(9): 1097; Author Reply 1097-8, 2008

Autologous Serum Eye Drops for Post-Chemical Injuries and Corneal Epithelial Defects. Macedonian Journal of Medical Sciences 6(4): 383-387, 2013

Combination of serum eye drops with hydrogel bandage contact lenses in the treatment of persistent epithelial defects. Graefe's Archive for Clinical and Experimental Ophthalmology 244(10): 1345-1349, 2006

Open clinical study of eye-drops containing tetrapeptides derived from substance P and insulin-like growth factor-1 for treatment of persistent corneal epithelial defects associated with neurotrophic keratopathy. British Journal of Ophthalmology 92(7): 896-900, 2008

Combined application of autologous serum eye drops and silicone hydrogel lenses for the treatment of persistent epithelial defects. Eye and Contact Lens 37(6): 370-373, 2011

The use of autologous serum tears in persistent corneal epithelial defects. Eye 18(6): 609-614, 2004